Cingulate
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cingulate and other ETFs, options, and stocks.About CING
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD).
CEOJennifer L. Callahan
CEOJennifer L. Callahan
Employees13
Employees13
HeadquartersKansas City, Kansas
HeadquartersKansas City, Kansas
Founded2012
Founded2012
Employees13
Employees13
CING Key Statistics
Market cap21.49M
Market cap21.49M
Price-Earnings ratio-0.69
Price-Earnings ratio-0.69
Dividend yield—
Dividend yield—
Average volume123.62K
Average volume123.62K
High today$4.07
High today$4.07
Low today$3.91
Low today$3.91
Open price$3.98
Open price$3.98
Volume77.79K
Volume77.79K
52 Week high$9.69
52 Week high$9.69
52 Week low$3.02
52 Week low$3.02
People also own
Based on the portfolios of people who own CING. This list is generated using Robinhood data, and it’s not a recommendation.